Overview A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 Status: Completed Trial end date: 2020-05-13 Target enrollment: Participant gender: Summary A clinical trial to compare the pharmacokinetics and tolerability of CKD-348 Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical